Lifecore Biomedical, Inc. LFCR Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s common stock, shares authorized (in shares)?
- Lifecore Biomedical, Inc. (LFCR) reported common stock, shares authorized (in shares) of $75M in Q1 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s common stock, shares authorized (in shares)?
- Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s common stock, shares authorized (in shares) has grown at a 22.5% compound annual growth rate (CAGR), from $50M to $75M.